NIM
CLDX icon

NEOS Investment Management’s Celldex Therapeutics CLDX Stock Holding History

NEOS Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,261
Closed -$512K – 604
2024
Q4 		$512K Sell
20,261
-6,331
-24% -$172K 0.01% 505
2024
Q3 		$904K Sell
26,592
-1,943
-7% -$74K 0.03% 393
2024
Q2 		$1.06M Buy
28,535
+16,625
+140% +$627K 0.04% 320
2024
Q1 		$500K Buy
11,910
+350
+3% +$14.4K 0.03% 383
2023
Q4 		$458K Buy
+11,560
New +$340K 0.04% 300

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return